Research outputs per year
Research outputs per year
Personal profile
Biography
I am the Head of School in the School of Pharmacy and Biomedical Sciences. I have research interests in design, synthesis, and biochemical evaluation of organic molecules.
Research Interests
My key research interests focus on the design, synthesis, and biochemical evaluation of organic molecules designed to act upon proteins for therapeutic benefits. Specialising in bio-analytical studies required to optimise organic molecules in a drug discovery project. Other interests include investigating the chemical and physical compatibility of intravenously delivered drugs in paediatric medicine.
Fingerprint
Dive into the research topics where Karen Ball is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Correction to: Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy (BMC Cancer, (2021), 21, 1, (427), 10.1186/s12885-021-08155-2)
Zaidieh, T., Smith, J. R., Ball, K. E. & An, Q., 10 May 2021, In: BMC Cancer. 21, 1, 528.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy
Zaidieh, T., Smith, J., Ball, K. E. & An, Q., 17 Apr 2021, In: BMC Cancer. 21, 18 p., 427.Research output: Contribution to journal › Article › peer-review
Open AccessFile124 Downloads (Pure) -
ROS as a novel indicator to predict anticancer drug efficacy
Zaidieh, T., Smith, J., Ball, K. E. & An, Q., 16 Dec 2019, In: BMC Cancer. 19, 14 p., 1224.Research output: Contribution to journal › Article › peer-review
Open AccessFile175 Downloads (Pure) -
Chemical and physical compatibility of continuous intravenous drug infusion combinations used in paediatric intensive care
Cole, C., Fox, A., Van Der Merwe, S., Dickson, L., Ball, K. E., Bevan, A., Hocking, A. & Pappachan, J., 19 Mar 2013, In: Critical Care. 17, 2, p. P383Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer
Brough, P. A., Aherne, W., Barril, X., Borgognoni, J., Boxall, K., Cansfield, J. E., Cheung, K.-M. J., Collins, I., Davies, N. G. M., Drysdale, M. J., Dymock, B., Eccles, S. A., Finch, H., Fink, A., Hayes, A., Howes, R., Hubbard, R. E., Ball, K. E., Jordan, A. M. & Lockie, A. & 17 others, , 24 Jan 2008, In: Journal of Medicinal Chemistry. 51, 2, p. 196-218Research output: Contribution to journal › Article › peer-review
Projects
- 2 Finished
-
ROS and mitochondrial genetic abnormalities as novel indicators for anti-cancer drug sensitivity
An, Q. (PI), Smith, J. (CoI) & Ball, K. (CoI)
1/10/17 → 30/09/21
Project: Research
-
Chemical and Physical Compatibility of Continuous Intravenous Drug Infusion Combinations Used in Paediatric Intensive Care
VdMerwe, M. (PI) & Ball, K. (CoI)
Neonatal and Paediatric Pharmacists Group
1/09/11 → 30/04/15
Project: Research